Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2025

Conditions

Acute Respiratory Distress Syndrome

Interventions

BIOLOGICAL

UMC119-06

Cohort 1: Low does of UMC119-06；Cohort 2: Medium does of UMC119- 06；Cohort 3: High does of UMC119-06

Trial Locations (1)

Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City